EFLM WEBINAR: Isolation, characterization and cryopreservation of hematopoietic stem cells from cord blood units
25 January 2022 at h. 18.00 CET (duration 1 h)
Speaker: Panagiotis Mallis (Greece)
Moderator: Stathis Michalopoulos (GR)
Cilck here to register
The umbilical cord blood (UCB) corresponds to a rich source of hematopoietic stem cells (HSCs), which has been thoroughly investigated in the last years. The cord blood HSCs can be applied as an alternative to bone marrow transplantation, treating in this way a wide range of haematological, immunological, and genetic disorders. However, cord blood donation agreed by signed informed consent from the mothers must be initially established. Furthermore, more studies have provided significant evidence regarding the advantages of the UCB HSCs, such as the non-invasive isolation, prompt processing and cryopreservation. Considering the above, the current lecture will focus on the state-of-the-art modern UCB HSCs isolation, characterization, and cryopreservation procedures.
